Smart Immune
Research - Paris, Île-de-France, France
Smart Immune Employees
Smart Immune Senior Management
Smart Immune Details
Through its groundbreaking "Ex vivo" Thymus technology, Smart Immune is focused on developping T cell progenitors-based cell and gene therapy enabling a rapid recovery of a fully potent immune system to fight cancers and infections. This new generation of T cell medicine can disrupt immune oncology medical practice while diminishing significantly graft versus host disease, infections and relapses .Its disruptive and proprietary Thymus ex vivo technology can differentiate hematopoietic stem cell into T progenitors in 7 days versus the usual 12 months expected in human physiology . Multipotent, enabling short and long lasting results, this fast and safe immune recovery is instrumental to imrove one year survival for patient affected by refractory actute leukemia; it has a large broad of applications regarding all T cell therapies in immunology, oncology and hematology. With two programs already in clinic for SCID and High risk AML, two phase I/II for pediatric and adult leukemia to begin soon at MSKCC, a dedicated program to milli fluidic automatization enabling scale up and out bioproduction, Smart Immune aims to change the future of allogenic engineered T cell therapy. .
Smart Immune Technologies
Load Balancers
Varnish
CMS
WordPress.org
Email Marketing
SendInBlue
Email Delivery
MailJet
Hosting
Amazon AWS
Other
Mobile Friendly